Table 3.
Management changes for patients after inappropriate therapy and implications on further events (SMART Pass™ = SP), total 27 patients
| Management action | SP enabled at time of IT (n = 16) | SP disabled at time of IT (n = 11) | Further IT after change (16 ± 15.5 months) |
|---|---|---|---|
| Change in sensing vector | 10 | 6 | 0 |
| Increase device detection rate (conditional zone from 200 to 220 b.p.m.) | 1 | 0 | 0 |
| Lead re-positioning | 1 | 1 | 0 |
| Temporary deactivation (1 week) | 0 | 2 | 0 |
| No changes | 3 | 0 | 2 |
| Reactivate SP and increase gain | 0 | 1 | 0 |
| Medical management (beta-blockers) | 1 | 0 | 0 |
| Transvenous device implant | 0 | 1 | 0 |